^
Association details:
Evidence:
Evidence Level:
Sensitive: C2 – Inclusion Criteria
Go to data
Title:

A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)

Excerpt:
...3.Histologically or cytologically confirmed ALK positive relapsed or refractory Anaplastic Large Cell Lymphoma....
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

2940 Phase I Study of Tq-B3101 in Pediatric Patients with Relapsed/Refractory Anaplastic Lymphoma Kinase Positive Anaplastic Large Cell Lymphoma

Published date:
11/03/2022
Excerpt:
The ORR was 100%, with four patients achieving complete response (CR) and three patients achieving a partial response (PR)….Our preliminary results suggest that TQ-B3101 has significant clinical activity in children with R/R ALK+ ALCL. Responses were durable and ongoing, and treatment was well tolerated.
DOI:
https://doi.org/10.1182/blood-2022-164661